Helping you to deliver value and prepare for funding rounds and/or IPO
Investing in Life Sciences - Realising value
EY are delighted to invite you to an interactive session, which is designed to sha0re a range of market perspectives and broader insights arising from a recent EY study centred on the key topic of realising value from data.
The event will take place on Tuesday, 10 December 2019 at the Tanner Warehouse in London, and will span three inter-related themes:
- Insights relating to the current funding landscape including a third-platform designed to facilitate dialogue between growth companies and Institutional Capital
- How can we place a value on health care data - key headlines from a recent study on the realisation of value from data and reflections on related market issues
- An overview of best practice IPO-related insights to facilitate discussion as to what readiness really means and involves. Focused on the US listing process, this will include discussion on timelines, regulatory and financial reporting requirements.
Tuesday, 10 December 2019
10:30 Registration and networking
11:15 Session 1, Funding Landscape
12:15 Session 2, Value on health care data
13:45 Session 3, Best practise IPO-related insights.
15:00 Approximate close
50 Bermondsey Street
This seminar is free of charge and places are allocated on a first come, first served basis.
To register, please email Ruby Sharoon-Khan
Please contact Ruby Sharoon-Khan if you have any further queries.
EY is a global leader in assurance, tax, transaction and advisory services. With over 400 employees in our Cambridge and Luton offices, our teams provide a range of services to a variety of sectors, including manufacturing, life sciences, consumer products and retail, technology, real estate and construction, health, and the public sector. The broad array of companies across the East allows us to bring real, relevant and key insights to our clients.